Nuvation Bio NUVB Deferred Tax Liabilities
Deferred Tax Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesOther.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's deferred tax liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's deferred tax liabilities?
- Nuvation Bio (NUVB) reported deferred tax liabilities of $0 in Q4 2025.
- How has Nuvation Bio's deferred tax liabilities changed year-over-year?
- Nuvation Bio's deferred tax liabilities decreased by 100.0% year-over-year, from $3.59M to $0.
- What is the long-term trend for Nuvation Bio's deferred tax liabilities?
- Over 5 years (2020 to 2025), Nuvation Bio's deferred tax liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $1K to $0.
- What does deferred tax liabilities mean?
- Future tax obligations from temporary differences — most commonly accelerated tax depreciation that creates higher current tax deductions than book depreciation.